Navigation Links
Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM)

" on its ranking of the world's most respected biopharmaceutical employers.

For more information about AstraZeneca, please visit: http://www.astrazeneca-us.com

The statements herein include forward-looking statements. By their nature, forward-looking statements and forecasts involve risk and uncertainty. For a discussion of those risks and uncertainties please see the company's Annual Report/Form 20-F for 2006.


    References

      1. Batchelor T et al. ASCO June 2007, Abstract no. 2001

      2. Wedge et al., 2005 Cancer Research Paper Wedge SR et al: AZD2171: a

         highly potent, orally bioavailable, vascular endothelial growth

         factor receptor-2 tyrosine kinase inhibitor for the treatment of

         cancer. Cancer Res. 2005 65(10):4389-400.

      3. Sridhar S et al.  ASCO June 2007, Abstract no. 5093

      4. van Herpen CML et al.  ASCO June 2007 Abstract no. 3560


    Katie Neff

    AstraZeneca

    302-885-9960
katie.neff@astrazeneca.com

CONTACT: Katie Neff of AstraZeneca, +1-302-885-9960, katie.neff@astrazeneca.com

Web site: http://www.cancer.gov//http://www.astrazeneca-us.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia

Post Your Comments:
(Date:11/24/2009)...ORK,Nov.24/PRNewswire-FirstCall/--KeryxBiopharmace...ntsur,theCompany,sChiefExecutiveOfficer,isschedule...ferencebeingheldinNewYorkCity. ,, Mr.Bentsur,sp...dat10:30AMETandwillbeaccessiblefromtheInvestorInfo...s.keryx.com .Anarchivedversionofthewebcastwillbeav...
(Date:11/23/2009)...INNATI,Nov.23/PRNewswire-FirstCall/--HealthWarehou...-orderpharmacy,todayannounceditsfinancialresultsfo...portedquarterlyrevenueof$1,006,721,drivenbyheavygr...arginsincreased13.0%year-over-yearto34.6%andthenet...86,299forthethreemonthsendedSeptember30,2008. ,...
(Date:11/23/2009)...YVALE,Calif.,Nov.23/PRNewswire-FirstCall/--Accuray...dofradiosurgery,announcedtodaythatitsmanagementiss...careConferenceinNewYorkonTuesday,December1,2009at9...eJ.P.MorganSmall/MidCapConferenceinNewYorkonThursd...livewebcastofeachpresentationwillbeavailableonline...
Breaking Medicine Technology:Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 3Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference 2Cardiogenesis Announces Presentation of its PHOENIX 28R 29 Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally In 4536 1Cardiogenesis Announces Presentation of its PHOENIX 28R 29 Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally In 4536 2Cardiogenesis Announces Presentation of its PHOENIX 28R 29 Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally In 4536 3ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 1ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 2ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 3ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 5EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 1EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 2
...NCINNATI, Dec. 18 Medpace, a leading global,full-...pening a 50 bed,clinical pharmacology unit in Cinc...it (Medpace CPU) is a state-of-the-art Phase I, II...cokinetic/pharmacodynamic,studies utilizing human ...dpace CPU is led by Jean Siebenaler, MD, who has e...
...SHINGTON, Dec. 18 The willingness to,participate ...e is not,affected by the investigator,s financial ...study reported in an article in the latest issue o...Food and Drug Law Institute., Clinical studies ar...d,certain devices. These studies are conducted by ...
Other Medicine Technology:Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio 2Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio 3Clinical Trial Participation Unaffected by Disclosure of Investigator's Financial Stake, Food and Drug Law Journal Article Finds 2
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--Jamba,Inc.(Nasdaq: J...ing,theEZ-2MAKE!JambaJuice(TM)SmoothieandIcePopMak...smoothie-makingexperiencetochildrennationwide.Crea...SmoothieandIcePopMakerwillbeavailableataleadingtoy...vailabletoadditionalU.S.retailersbeginningJanuary2...
(Date:11/24/2009)...Health Care Reform creates numerous challenges for...ic care treatment—and suggests the need to r... Alpharetta, GA (Vocus) November 24, 2009 -- The ... is controversial, to say the least -- with practi...cy makers all weighing in with their views on what...
(Date:11/24/2009)...Slate and New Markets build on their combined stre... , Baltimore, Md. (PRWEB)...atecap.com ), a private equity firm based in Balti... www.newmarketsvp.com ), a venture capital firm ba...t they have acquired Ecoast Sales Solutions, Ltd. ...
(Date:11/24/2009)...Two expert therapists offer advice on the topic of...verb: to leave completely and finally; forsake ut...uver, Canada (Vocus) November 24, 2009 -- Dr. Suza...he second webinar is its groundbreaking "The ... from MyShrink.com ( http://www.myshrink.com )., ,...
(Date:11/24/2009)...Sinusitis patients life is regularly impacted by a...s non-invasive nasal sinus treatment with Nasal ne...es of Sinusitis without any limitation or interfer...s found 82.9% of patients treated with Sinus Dynam...article diameter of 3.2 µm had a “good...
Breaking Medicine News(10 mins):Health News:Jamba Juice and Think Wow Toys Bring the Smoothie Experience Home With Debut of Jamba Branded Toy Blender 2Health News:Jamba Juice and Think Wow Toys Bring the Smoothie Experience Home With Debut of Jamba Branded Toy Blender 3Health News:Jackson & Coker Industry Report Addresses Health Care Reform 2Health News:Jackson & Coker Industry Report Addresses Health Care Reform 3Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 2Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 3Health News:Home For the Holidays: MyShrink.com Announces the Second in its Successful Six-Part Webinar Series: "Abandonment: The Hidden Fear" 2Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 2Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 3Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 4
...d, Inc.,(Nasdaq: ENMD ), a clinical-stage pharmac...eatment of cancer and inflammatory diseases, today... as Director, effective,June 5, 2008., (Logo: ht... Company chart its path forward in,multi-mechanism...
... pressure-regulating enzyme in mice, researchers h...,s ability to sense tumor growth. , When scientis...ed mice that make more angiotensin-converting enzy...ll bits of protein that originate from the tumors,...
...al Equipment Providers Out of,Business and Disrupt...Charlotte Area, ARLINGTON, Va., April 7, 2008 A ...quipment (DME) scheduled to be,implemented in the ...any of the 174,319 seniors and people with,disabil...
...During ,IDOL GIVES BACK, Wednesday, ...2008 Alicia in Africa: Journey to,the Motherland ...nning,musician and Keep a Child Alive (KCA) Co-Fou... and she is leading the,effort to spread the messa...
...e,Corporation (NYSE: ALB ) will hold its quarterl... on Tuesday, April 22, 2008, at 9:00am ET., This ...ccessed at,Albemarle Corporation,s Web site at ht... International Dial In # 617-614-4909 Passcode...
...viders Out of Business and,Disrupt Services to as ...ustin, Beaumont, El Paso, Houston, McAllen, and Sa... A new Medicare,bidding program for durable medic...and could disrupt services for many,of the 481,835...
Other Medicine News:Health News:Dr. Ronald E. Cape to Retire from EntreMed Board of Directors 2Health News:Dr. Ronald E. Cape to Retire from EntreMed Board of Directors 3Health News:Blood pressure enzyme can have tumor-sensing role 2Health News:Medicare Bidding Program for Charlotte, N.C. is Plagued by Errors, Says American Association for Homecare 2Health News:Medicare Bidding Program for Charlotte, N.C. is Plagued by Errors, Says American Association for Homecare 3Health News:African Journey of a Lifetime With Alicia Keys! - Documentary Follows Keep a Child Alive's Outreach to Communities Affected With HIV/AIDS 2Health News:African Journey of a Lifetime With Alicia Keys! - Documentary Follows Keep a Child Alive's Outreach to Communities Affected With HIV/AIDS 3Health News:African Journey of a Lifetime With Alicia Keys! - Documentary Follows Keep a Child Alive's Outreach to Communities Affected With HIV/AIDS 4Health News:Albemarle Corporation's First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 9:00am ET 2Health News:Medicare Bidding Program for Dallas, Texas is Rife with Errors, Says American Association for Homecare 2Health News:Medicare Bidding Program for Dallas, Texas is Rife with Errors, Says American Association for Homecare 3
...cular Biology Buffers are ready-to-use solutions i...tions. Each reagent is prepared with 18 megOhm wat... into sterile bottles., Reliable - Manufactured ...nsure lot-to-lot consistency. , High Quality - No...
Terrific Broth
NZ Broth
S.O.C. Medium
Medicine Products: